J Pediatr Genet 2019; 08(01): 027-032
DOI: 10.1055/s-0038-1669445
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Failure to Thrive: An Expanded Differential Diagnosis

Alexandra Lazzara
1   Department of Pediatrics, Penn State Health Children's Hospital, Hershey, Pennsylvania, United States
2   Department of Pediatrics, Johns Hopkins Children's Center, Baltimore, Maryland, United States
,
Carrie Daymont
1   Department of Pediatrics, Penn State Health Children's Hospital, Hershey, Pennsylvania, United States
,
Roger Ladda
1   Department of Pediatrics, Penn State Health Children's Hospital, Hershey, Pennsylvania, United States
,
Jordan Lull
1   Department of Pediatrics, Penn State Health Children's Hospital, Hershey, Pennsylvania, United States
,
Can Ficicioglu
3   Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
,
Jennifer L. Cohen
3   Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
,
Justen Aprile
1   Department of Pediatrics, Penn State Health Children's Hospital, Hershey, Pennsylvania, United States
› Author Affiliations
Further Information

Publication History

09 June 2018

23 July 2018

Publication Date:
31 August 2018 (online)

Abstract

The patient is a term 6-month-old male, who presented with failure to thrive since birth. History was remarkable for suspected milk and soy protein allergy, gastroesophageal reflux, constipation, and abdominal distension that was present since birth. He was losing weight despite oral intake of over 100 kcal/kg per day. Prior workup including laboratory studies, abdominal X-ray, upper gastrointestinal series with fluoroscopy, barium enema, and abdominal ultrasound were all within normal limits. The patient's history, diagnostic evaluation, and final diagnosis are revealed. This case highlights a rare condition presenting as failure to thrive, a common problem with a wide differential diagnosis.

 
  • References

  • 1 Olsen EM. Failure to thrive: still a problem of definition. Clin Pediatr (Phila) 2006; 45 (01) 1-6
  • 2 Mei Z, Grummer-Strawn LM, Thompson D, Dietz WH. Shifts in percentiles of growth during early childhood: analysis of longitudinal data from the California Child Health and Development Study. Pediatrics 2004; 113 (06) e617-e627
  • 3 Ramsay M, Gisel EG, Boutry M. Non-organic failure to thrive: growth failure secondary to feeding-skills disorder. Dev Med Child Neurol 1993; 35 (04) 285-297
  • 4 Reilly SM, Skuse DH, Wolke D, Stevenson J. Oral-motor dysfunction in children who fail to thrive: organic or non-organic?. Dev Med Child Neurol 1999; 41 (02) 115-122
  • 5 Zenel Jr JA. Failure to thrive: a general pediatrician's perspective. Pediatr Rev 1997; 18 (11) 371-378
  • 6 Berwick DM, Levy JC, Kleinerman R. Failure to thrive: diagnostic yield of hospitalisation. Arch Dis Child 1982; 57 (05) 347-351
  • 7 Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). Available at: https://omim.org/ . Accessed December 7, 2017
  • 8 Sills RH. Failure to thrive. The role of clinical and laboratory evaluation. Am J Dis Child 1978; 132 (10) 967-969
  • 9 Nurminen S, Kivelä L, Taavela J. , et al. Factors associated with growth disturbance at celiac disease diagnosis in children: a retrospective cohort study. BMC Gastroenterol 2015; 15: 125
  • 10 Jaffe AC. Failure to thrive: current clinical concepts. Pediatr Rev 2011; 32 (03) 100-107 , quiz 108
  • 11 Abramov A, Schorr S, Wolman M. Generalized xanthomatosis with calcified adrenals. AMA J Dis Child 1956; 91 (03) 282-286
  • 12 Assmann G, Fredrickson DS, Sloan HR, Fales HM, Highet RJ. Accumulation of oxygenated steryl esters in Wolman's disease. J Lipid Res 1975; 16 (01) 28-38
  • 13 Fitoussi G, Nègre-Salvayre A, Pieraggi MT, Salvayre R. New pathogenetic hypothesis for Wolman disease: possible role of oxidized low-density lipoproteins in adrenal necrosis and calcification. Biochem J 1994; 301 (Pt 1): 267-273
  • 14 Aguisanda F, Thorne N, Zheng W. Targeting Wolman disease and cholesteryl ester storage disease: disease pathogenesis and therapeutic development. Curr Chem Genomics Transl Med 2017; 11: 1-18
  • 15 Reiner Ž, Guardamagna O, Nair D. , et al. Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis 2014; 235 (01) 21-30
  • 16 Bernstein DL, Hülkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol 2013; 58 (06) 1230-1243
  • 17 Lysosomal acid lipase deficiencies: the Wolman disease/cholesteryl ester storage disease spectrum. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW. , et al., eds. The Online Metabolic and Molecular Bases of Inherited Disease. Chap. 142. New York: McGraw Hill Education; 2018
  • 18 Goldstein JL, Brown MS. Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis. Circulation 1987; 76 (03) 504-507
  • 19 Burton BK, Balwani M, Feillet F. , et al. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency. N Engl J Med 2015; 373 (11) 1010-1020
  • 20 Jones SA, Rojas-Caro S, Quinn AG. , et al. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study. Orphanet J Rare Dis 2017; 12 (01) 25
  • 21 The WHO Child Growth Standards. Available at: http://www.who.int/childgrowth/standards/en/ ; Accessed January 2, 2018
  • 22 Kahramaner Z, Erdemir A, Arik B, Bilgili G, Tekin M, Genc Y. Reference ranges of liver and spleen dimensions in term infants: sonographic measurements. J Med Ultrason (2001) 2015; 42 (01) 77-81
  • 23 Ficicioglu C, An Haack K. Failure to thrive: when to suspect inborn errors of metabolism. Pediatrics 2009; 124 (03) 972-979